Roche Escapes Stock-Drop Suit Over Cancer Drug Results
Roche Holding AG has knocked down a putative securities class action after a New Jersey federal judge concluded that the pharmaceutical giant and its executives did not make false or misleading...To view the full article, register now.
Already a subscriber? Click here to view full article